Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 October 2010Website:
http://www.pacb.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 23:53:23 GMTDividend
Analysts recommendations
Institutional Ownership
PACB Latest News
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.37, indicating a +0.74% shift from the previous trading day.
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease Research MENLO PARK, Calif. , June 10, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), today announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation.
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Zacks.com users have recently been watching Pacific Biosciences (PACB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PACB has been closely monitored by Zacks.com users recently, making it important to examine its future prospects.
PacBio's revenue growth in the first quarter may have been impacted by a growing number of customers postponing instrument purchases and a decrease in consumable shipments.
PacBio's (PACB) strong product demand and top-line growth raise optimism about the stock.
PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
What type of business is Pacific Biosciences of California?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
What sector is Pacific Biosciences of California in?
Pacific Biosciences of California is in the Healthcare sector
What industry is Pacific Biosciences of California in?
Pacific Biosciences of California is in the Medical Devices industry
What country is Pacific Biosciences of California from?
Pacific Biosciences of California is headquartered in United States
When did Pacific Biosciences of California go public?
Pacific Biosciences of California initial public offering (IPO) was on 27 October 2010
What is Pacific Biosciences of California website?
https://www.pacb.com
Is Pacific Biosciences of California in the S&P 500?
No, Pacific Biosciences of California is not included in the S&P 500 index
Is Pacific Biosciences of California in the NASDAQ 100?
No, Pacific Biosciences of California is not included in the NASDAQ 100 index
Is Pacific Biosciences of California in the Dow Jones?
No, Pacific Biosciences of California is not included in the Dow Jones index
When does Pacific Biosciences of California report earnings?
The next expected earnings date for Pacific Biosciences of California is 02 August 2024